Intercure Ltd. — Annual Report 2026

May 1, 2026

20F לשנת 2025 false

אינטרקיור בע"מ	2 380
INTERCURE LTD
Corporation no: 512051699	12424
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	01/05/2026
	www.isa.gov.il			www.tase.co.il				Reference:	2026-02-040363	Time of broadcast: 08:14 08:14

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on20F לשנת 2025

INTERCURE_LTD_04-28-2026_Form_20-F_Bannerless_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1	Date of revision of form structure: 06/08/2024
Address: Medinat ha-Yehudim Street 85 , Herzliya 4676670   Israel , Tel: 077-4605012 , Fax: 09-7680244
E-mail address: office@canndoc-pharma.com   Company site: www.Intercure.co
Previous names of reporting entity:
Name of the Signatory: Kantor Ronen Position of Signatory in the reporting corporation: External Legal Counsel Name of Employer Company:
Address: BSR Tower 4, 33rd floor, Masada Street 7 , Bney Brak 5126112 Telephone: 03-6109100 Facsimile: 03-6133372 E-mail: rsoulema@dtkgg.com 1